• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[癌症内科治疗的组织形式——瑞士临床癌症研究工作组的经验]

[Organizational forms in the internal medicine treatment of cancer--experiences of the Swiss Working Group for Clinical Cancer Research].

作者信息

Obrecht J P

出版信息

Z Gesamte Inn Med. 1987 Jan 1;42(1):2-7.

PMID:3577264
Abstract

The treatment and care of the patient suffering from cancer which often extends over months, even years and in which participate numerous specialists of the fields is, in order to be optimally effective, bound to organisational prerequisites. This particularly concerns the therapeutic research. This forms the framework in the centre of which shall stand the physician to which the patient has confidence. In Switzerland this is the family doctor. The participating specialists assume their specific tasks in every case for a limited period. Hereby the interdisciplinary talk often plays a decisive role. Not infrequently the only unilateral care overlooks important aspects, which are precarious for the course of the disease. The internal therapy of cancer has to a large extent the character of empiricism, to which the standards of the strongly controlled experiment are to be applied. During the last decenniums the methodology of the clinically controlled study was permanently extended and improved. Many studies, particularly the randomized ones, may be performed only multicentrically. Such a cooperation is realized in the Swiss working group for clinical cancer research. With the help of such an instrument relevant clinical questions can be investigated and answered, which further the treatment of the cancer diseases step by step.

摘要

癌症患者的治疗和护理通常会持续数月甚至数年,涉及众多该领域的专家。为了达到最佳效果,这必然需要组织方面的前提条件。这一点在治疗研究中尤为重要。治疗研究构成了一个框架,其核心应该是患者信任的医生。在瑞士,这个医生就是家庭医生。参与治疗的专家在每种情况下都会在有限的时间内承担各自特定的任务。因此,跨学科交流往往起着决定性作用。很多时候,单方面的治疗常常会忽略一些对疾病进程至关重要的方面。癌症的内部治疗在很大程度上具有经验主义的特征,需要应用严格对照实验的标准。在过去几十年里,临床对照研究的方法不断扩展和完善。许多研究,尤其是随机研究,只能多中心进行。瑞士临床癌症研究工作组就实现了这样的合作。借助这样一种手段,可以研究并回答相关的临床问题,从而逐步推动癌症疾病的治疗。

相似文献

1
[Organizational forms in the internal medicine treatment of cancer--experiences of the Swiss Working Group for Clinical Cancer Research].[癌症内科治疗的组织形式——瑞士临床癌症研究工作组的经验]
Z Gesamte Inn Med. 1987 Jan 1;42(1):2-7.
2
Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer.参与或未参与随机对照试验的乳腺癌患者的护理评估:法国国家抗癌联盟临床试验患者委员会的一份报告
J Clin Oncol. 2007 Jul 20;25(21):3038-44. doi: 10.1200/JCO.2006.08.9367. Epub 2007 May 29.
3
[Internistic cancer therapy--introduction to the theme].[内科癌症治疗——主题介绍]
Z Gesamte Inn Med. 1978 Jul 15;33(14):449-54.
4
Surgeons: A Future Role in Clinical Trials?外科医生:在临床试验中未来会扮演何种角色?
Oncologist. 1997;2(3):V-VI.
5
[Problems in internal medicine therapy of breast cancer].[乳腺癌内科治疗中的问题]
Z Gesamte Inn Med. 1987 Mar 1;42(5):134-7.
6
[Respective indications for hormone therapy, induction chemotherapy and adjuvant chemotherapy in breast cancer without clinically discernable distant metastases].[激素治疗、诱导化疗及辅助化疗在无临床可辨远处转移乳腺癌中的各自适应证]
Rev Med Brux. 1995 Jul-Aug;16(4):242-4.
7
[Acute leukemias and tumors of childhood--a problem solved?].[儿童急性白血病和肿瘤——问题解决了吗?]
Schweiz Med Wochenschr. 1983 Sep 10;113(36):1285-8.
8
[Therapy of metastatic breast cancer].
Ther Umsch. 1993 May;50(5):352-8.
9
Adjuvant therapy for breast cancer.乳腺癌辅助治疗
Minerva Ginecol. 2005 Jun;57(3):305-26.
10
[Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].[局部晚期非炎性乳腺癌的联合化疗及术前放疗治疗:120例患者的最新结果]
Cancer Radiother. 2004 Jun;8(3):155-67. doi: 10.1016/j.canrad.2004.01.001.